申请人:Fuji Chemical Industry Company Limited
公开号:US04116972A1
公开(公告)日:1978-09-26
Hydrogenated 1-oxo-isoindoline derivatives having a strong anti-inflammatory activity may be prepared by reducing the corresponding hydrogenated 1,3-dioxo-isoindoline derivative to the 3-hydroxy-1-oxo-isoindoline derivative and then further reducing, dehydrating or hydrolizing this compound.
具有强抗炎活性的氢化1-氧代异吲哚衍生物可以通过将相应的氢化1,3-二氧代异吲哚衍生物还原为3-羟基-1-氧代异吲哚衍生物,然后进一步还原、脱水或水解该化合物来制备。